Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection

Journal of Medical Virology

Volumn 80, Issue 5, 2008, Pages 847-855

  Yamada, Rika ^a   Sasagawa, Toshiyuki ^a   Kirumbi, Leah W ^b   Kingoro, Alan ^b   Karanja, Dominic K ^b   Kiptoo, Michael ^b   Nakitare, George W ^b   Ichimura, Hiroshi ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

CD4+ T cell count; Cervical abnormality; HIV; HIV RNA; HPV

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KENYA; MAJOR CLINICAL STUDY; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; VAGINAL SMEARS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 41849130647     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21170     Document Type: Article

References (22)

1. Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. 2000. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 151:1148-1157.
2. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG. 2004. Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co-infection on HPV genotype distribution. J Med Virol 73:481-485.
3. Claeys P, De Vuyst H, Mzenge G, Sande J, Dhondt V, Temmerman M. 2003. Integration of cervical screening in family planning clinics. Int J Gynaecol Obstet 81:103-108.
4. Clark RA, Brandon W, Dumestre J, Pindaro C. 1993. Clinical manifestations of infection with the human immunodeficiency virus in women in Louisiana. Clin Infect Dis 17:165-172.
5. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062.
6. Frisch M, Biggar RJ, Goedert JJ. 2000. Human papillomavirus-associated cancer in patients with immunodeficiency virus infection and acquired immunodeficiency syndrome. For the AIDS-Cancer Match Registry Study Group. J Natl Cancer Inst 92:1500-1510.
7. Gichangi P, De Vuyst H, Estambale B, Rogo K, Bwayo J, Temmerman M. 2002. HIV and cervical cancer in Kenya. Int J Gynaecol Obstet 76:55-63.
8. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. 1998. Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839.
9. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
10. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 92:818-825.
11. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. 1997. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 89:76-80.
12. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P. 1999. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquire Immune Defic Syndr 21: 33-41.
13. Maurer D, Felzmann T, Knapp W. 1990. A single laser flow cytometry method to evaluate the binding of three antibodies. J Immunol Methods 135:43-47.
14. Ministry of Health, Kenya. 2005. AIDS in Kenya trends, interventions and impact, 7th edition, 2005 National AIDS and STI control program (NASCOP).
15. Palefsky J. 2006. Biology of HPV in HIV infection. Adv Dent Res 19:99-105. Review.
16. Parkin DM, Bray FI, Devesa SS. 2001. Cancer burden in the year 2000.The global picture. Eur J Cancer 37:4-66.
17. Peto J, Gilham C, Fletcher O, Matthews FE. 2004. The cervical cancer epidemic that screening has prevented in UK. Lancet 364:249-256.
18. Sasagawa T, Tani M, Yasuda H, Khadijeh KA, Sakai A, Fukae T, Ukita T, Yamazaki H, Satake S, Nakano T, Inoue M. 2005. Sexual behaviour and high risk human papillomavirus infections in Japanese women. Sex Transm Infect 81:280-282.
19. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N, Forum Group Members; Bethesda 2001 Workshop. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114-2119.
20. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DL, Ow-grade SIL, Verberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
21. Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, Quint W. 1999. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet 65:171-181.
22. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. 2000. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 85:206-210.